MRNA vs TASK
Moderna Inc (MRNA) versus Taskus Inc (TASK) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Taskus Inc (TASK) is a information technology services company listed on NASDAQ.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
Latest reported TASK revenue for 2024-12-31 was $995.0M. Net income was $45.9M. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
MRNA currently screens at market cap $24.52B. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
Not investment advice. Open the MRNA and TASK stock pages for the full models.
Not investment advice.